Abaxis Q4 Profit From Cont. Ops. Decreases - Quick Facts

(RTTNews) - Abaxis, Inc. (ABAX), a medical products company manufacturing point-of-care blood analysis systems, reported fourth quarter income from continuing operations of $3.8 million or $0.17 per share, compared to $4.1 million or $0.19 per share, prior year. Total earnings per share was $0.50, compared to $0.17.

On average, eight analysts polled by Thomson Reuters expected the company to report profit per share of $0.27 for the quarter. Analysts' estimates typically exclude special items.

Revenue increased to $52.02 million from $39.22 million last year. Analysts expected revenue of $55.52 million for the quarter.

Abaxis announced its Board declared an increase in the quarterly dividend from $0.10 to $0.11 per common share, to be paid on June 18, 2015, to all shareholders of record as of the close of business on June 4, 2015.